Countering the problem of falsified and substandard drugs / Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies.

By: Institute of Medicine (U.S.). Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products [issuing body.]Contributor(s): Buckley, Gillian J [editor.] | Gostin, Lawrence O. (Lawrence Ogalthorpe) [editor.] | Institute of Medicine. Board on Global Health [issuing body.]Material type: TextTextPublisher: Washington, District of Columbia : National Academies Press, [2013]Copyright date: 2013Description: 1 online resource (375 pages) : illustrations (chiefly color), color mapsContent type: text Media type: computer Carrier type: online resourceISBN: 9780309269407Subject(s): Pharmaceutical industry -- Quality control | Fraud -- PreventionGenre/Form: Electronic books.Additional physical formats: Print version:: Countering the problem of falsified and substandard drugs.LOC classification: HD9665.5 | .I57 2013Online resources: Click to View
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Includes bibliographical references.

Description based on print version record.

Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.

There are no comments on this title.

to post a comment.